STANDARDIZATION INTERNATIONAL
UNION OF IMMUNOLOGICAL SOCIETIES (AutoAb.org)
| Publications |
| Tan EM, Feltkamp TEW, Smolen JS, Butcher B, Dawkins R, Fritzler MJ, Gordon T, Hardin JA, Kalden JR, Lahita RG, Maini RN, McDougal JS, Rothfield NF, Smeenk RJ, Takasaki Y, Wiik A, Wilson MR, Koziol JA. Range of antinuclear antibodies in "healthy" individuals. Arthritis Rheum 40: 1601-1611, 1997. |
| Smolen JS, Butcher B, Fritzler MJ, Gordon T, Hardin J, Kalden JR, Lahita R, Maini RN, Reeves W, Reichlin M, Rothfield N, Takasaki Y, van Venrooij WJ, Tan EM. Reference sera for antinuclear antibodies: II. Further definition of antibody specificities in international ANA reference sera by immunofluorescence and western blotting. Arthritis Rheum. 40: 413-418, 1997. |
| Tan EM, Smolen JS, McDougal JS, Butcher BT, Conn D, Dawkins R, Fritzler MJ, Gordon T, Hardin JA, Kalden JR, Lahita RG, Maini RN, Rothfield NF, Smeenk R, Takasaki Y, van Venrooij WJ, Wiik A, Wilson M, Koziol JA. A critical evaluation of enzyme immunoassays for the detection of antinuclear antibodies of defined specificities. I. Precision, sensitivity and specificity. Arthritis Rheum 42: 455-64, 1999. pdf 493kB |
| Tan EM, Smolen JS, McDougal JS, Fritzler MJ, Gordon T, Hardin JA, Kalden JR, Lahita RG, Maini RN, Reeves WH, Rothfield NF, Takasaki Y, Wiik A, Wilson M, Koziol JA. A critical evaluation of enzyme immunoassay kits for the detection of antinuclear antibodies of defined specificities. II. Potential for quantitation of antibody content. J Rheumatol 29: 68-74, 2002. |
| Fritzler MJ, Wiik A, Fritzler ML, Barr SG. The use and abuse of commercial kits used to detect autoantibodies. Arthritis Res & Ther 5:192-201, 2003. pdf 112kB |
| Fritzler MJ, Wiik A, Tan EM, Smolen JS, McDougal JS, Chan, EK, Gordon TP, Hardin JA, Kalden JR, Lahita RG, Maini RN, Reeves WH, Rothfield NF, Takasaki Y, Wilson M, Byrd MG, Slivka L, Koziol JA. A critical evaluation of enzyme immunoassay kits for the detection of antinuclear antibodies of defined specificities. III. Comparative performance characteristics of academic and manufacturers' laboratories. J. Rheumatol. 30:2374-2381, 2003. |
| Wiik, AS, Gordon, TP, Kavanaugh AG, Lahita RS, Reeves W, van Venrooij WJ, Wilson MR, Fritzler MJ. Cutting edge diagnostics in rheumatology: The role of patients, clinicians and laboratory scientists in optimizing the use of autoimmune serology. Arthritis Care & Res. 51: 291-298, 2004. pdf 129kB |
| Chan, EKL, Fritzler, MJ, Wiik, A, Andrade, LEC, Reeves, WH, Tincani, A, Meroni, PL, and the IUIS/WHO/AF/CDC committee for the standardization of autoantibodies in rheumatic and related diseases. AutoAbSC.Org – Autoantibody Standardization Committee in 2006. Autoimmunity Reviews 6:577–580, 2007 |
| Relevant publications |
| References for the anti-cardiolipin
monoclonal antibodies included in the reference reagents:
Tincani A, Allegri F, Sanmarco M, Cinquini M, Taglietti M, Balestrieri G, Koike T, Ichikawa K, Meroni P, Boffa MC. Anticardiolipin antibody assay: a methodological analysis for a better consensus in routine determinations -- a cooperative project of the European Antiphospholipid Forum. Thromb. Haemost. 86:575-83, 2001. pdf 163kB |
| Tincani A, Allegri F, Balestrieri G, Reber G, Sanmarco M, Meroni P, Boffa MC. Minimal requirements for antiphospholipid antibodies ELISAs proposed by the European Forum on antiphospholipid antibodies. Thromb. Res. 114:553-558, 2004. pdf 87kB |
| Reference for a discussion
of revised anti-DNA methods:
Riboldi P, Gerosa M, Moroni G, Radice A, Allegri F, Sinico A, Tincani A, Meroni PL. Anti-DNA antibodies: a diagnostic and prognostic tool for systemic lupus erythematosus? Autoimmunity. 38:39-45, 2005. pdf 85kB |
update 5/2008